Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.47 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | MAPT | P10636 | 3/20 | 0.38 |
| ▸ | GAA | P10253 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.37 |
| ▸ | HTR1B | P28222 | 1/20 | 0.37 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.36 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | ACHE | P22303 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11760305 | 0.86 | ESR1 (0.47) | ESR1ESR2TRPA1ATMMAPT | |
| SCHEMBL18092262 | 0.84 | HTT (0.40) | ESR1ESR2TRPA1ATMMAPT | |
| SCHEMBL2089504 | 0.84 | ESR1 (0.46) | ESR1ESR2TRPA1ATMMAPT | |
| SCHEMBL106500 | 0.82 | ESR1 (0.44) | ESR1ESR2TRPA1ATMMAPT | |
| SCHEMBL2089501 | 0.82 | ESR1 (0.44) | ESR1ESR2TRPA1ATMMAPT | |
| SCHEMBL3423206 | 0.82 | ESR1 (0.49) | ESR1ESR2TRPA1ATMMAPT | |
| SCHEMBL18092257 | 0.81 | ESR1 (0.41) | ESR1ESR2TRPA1ATMMAPT | |
| SCHEMBL4315585 | 0.80 | TAAR1 (0.50) | TAAR1KMT2ATSHRACHEALDH1A1 | |
| SCHEMBL8750528 | 0.79 | ESR1 (0.42) | ESR1ESR2TRPA1ATMMAPT | |
| SCHEMBL28594116 | 0.77 | ESR1 (0.41) | ESR1ESR2TRPA1ATMMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-4925462-A | FROM GAS FLOW THROUGH FROTH SCRUBBER; LIQUEFYING, SEPARATION | ARASIN GMBH (DE) | 1990-05-15 | — | — | US | claimed |
| CN-122011829-A | Nanoparticle, ink composition, light-emitting device, electronic device, and electronic device | 三星显示有限公司 | 2026-05-12 | — | — | CN | disclosed |
| CN-111315721-B | Organic mixtures and their use in organic electronic devices | 广州华睿光电材料有限公司 | 2023-06-06 | — | — | CN | disclosed |
| CN-115513253-A | Display device | 三星显示有限公司 | 2022-12-23 | — | — | CN | disclosed |
| CN-114686048-A | Nanoparticle ink composition, light emitting device, and method of manufacturing light emitting device | 三星显示有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114686047-A | Ink composition, light-emitting device, and method for manufacturing light-emitting device | 三星显示有限公司 | 2022-07-01 | — | — | CN | disclosed |
| CN-114678474-A | Nanocomposite, nanoparticle ink composition including the same, and light emitting device | 三星显示有限公司 | 2022-06-28 | — | — | CN | disclosed |
| CN-113764593-A | Light emitting device, electronic apparatus including the same, and method of manufacturing the light emitting device | 三星显示有限公司 | 2021-12-07 | — | — | CN | disclosed |
| US-20100298347-A1 | SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY | MERCK FROSST CANADA LTD (CA) | 2010-11-25 | — | — | US | disclosed |
| EP-2229373-A1 | SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY | Merck Frosst Canada Ltd. (CA) | 2010-09-22 | — | — | EP | disclosed |
| US-5376615-A | Pressure sensitive elements containing a salicylic acid resin and a phenolic resin | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1994-12-27 | — | — | US | disclosed |
| US-5248450-A | Pyrethroid insecticides, fungicides | DESOWAG MATERIALSCHUTZ GMBH (DE) | 1993-09-28 | — | — | US | disclosed |
| EP-0523697-A1 | Color-developing compositions and their use | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1993-01-20 | — | — | EP | disclosed |
| US-5039319-A | Purification, scrubbing | ARASIN GMBH (DE) | 1991-08-13 | — | — | US | disclosed |
| US-5023366-A | Reacted with a benzyl halide, alcohol or ether; for pressure sensitive elements | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1991-06-11 | — | — | US | disclosed |
| US-4925462-A | FROM GAS FLOW THROUGH FROTH SCRUBBER; LIQUEFYING, SEPARATION | ARASIN GMBH (DE) | 1990-05-15 | — | — | US | disclosed |
| US-4750934-A | Composition or concentrate for conserving wood and wood materials | DESOWAG-BAYER HOLZSCHUTZ GMBH (DE) | 1988-06-14 | — | — | US | disclosed |
| EP-0268878-A2 | Salicylic acid copolymers and their metal salts, production process thereof, color-developing agents comprising metal salts of the copolymers and color-developing sheets employing the agents | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1988-06-01 | — | — | EP | disclosed |
| US-4518806-A | Production of aryl alkyl ethers from methylbenzyl alcohol using bis-(dithiobenzyl)nickel(II) catalyst | ATLANTIC RICHFIELD COMPANY (US) | 1985-05-21 | — | — | US | disclosed |
| US-4514576-A | Production of aryl alkyl ethers from methylbenzyl alcohol using rhenium heptoxide catalyst | ATLANTIC RICHFIELD COMPANY (US) | 1985-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298347-A1 | SUBSTITUTED 2-NAPHTHOIC ACIDS AS ANTAGONISTS OF GPR105 ACTIVITY | GPR119, GPR52, GPR35 | ESR1 651/4885ESR2 139/4885TRPA1 325/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.